Health care stocks declined late Monday afternoon, with the NYSE Health Care Index down 1.1% and the Health Care Select Sector SPDR Fund (XLV) falling 1.2%.
The iShares Biotechnology ETF (IBB) rose 0.6%.
In corporate news, Emergent BioSolutions (EBS) shares jumped 4.7% after the Biomedical Advanced Research and Development Authority awarded a $50 million option to the company's existing contract for the purchase of Cyfendus.
Aspira Women's Health (AWH) shares were fractionally up after it said Monday that Chief Executive Nicole Sandford will leave the company due to a family health matter, effective immediately. President Sandra Milligan will serve as interim CEO while the company searches for a permanent successor, the company said.
President-elect Donald Trump told reporters his administration is going to "knock out" pharmacy benefit managers to bring down drug prices, Bloomberg reported. Shares of CVS Health (CVS), UnitedHealth (UNH), and Cigna (CI), which own the three largest pharmacy benefit managers, fell 5.6%, 4.5%, and 3.2% respectively.
Maia Biotechnology (MAIA) shares jumped over 8% after the firm said its investigational telomere-targeting agent THIO received a rare pediatric disease designation from the US Food and Drug Administration to treat pediatric-type diffuse high-grade gliomas.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。